Mutation frequencies and antibiotic resistance

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 7, 2000, Pages 1771-1777

  Martinez, J L ^a   Baquero, F ^b  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CHLORAMPHENICOL; NITROIMIDAZOLE DERIVATIVE; PENICILLIN G; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL MUTATION; CULTURE MEDIUM; DNA RECOMBINATION; DRUG CONCENTRATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC RESISTANCE; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MUTATION RATE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SHORT SURVEY;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, MICROBIAL; GENE DOSAGE; GENE FREQUENCY; MUTATION; SELECTION (GENETICS);

EID: 0033936567     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.7.1771-1777.2000     Document Type: Short Survey

References (77)

1. Alonso, A., E. Campanario, and J. L. Martinez. 1999. Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology 145:2857-2862.
2. Andersson, D. I., and B. R. Levin. 1999. The biological cost of antibiotic resistance. Curr. Opin. Microbiol. 2:489-493.
3. Baquero, F., and M. C. Negri. 1997. Selective compartments for resistant microorganisms in antibiotic gradients. Bioessays 19:731-736.
4. Baquero, F., M. C. Negri, M. I. Morosini, and J. Blazquez. 1997. The antibiotic selective process: concentration-specific amplification of low-level resistant populations. Ciba Found. Symp. 207:93-105.
5. Bjorkman, J., I. Nagaev, O. G. Berg, D. Hughes, and D. I. Andersson. 2000. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287:1479-1482.
6. Bjorkman, J., D. Hughes, and D. I. Andersson. 1998. Virulence of antibiotic-resistant Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 95:3949-3953.
7. Blazquez, J., M. I. Morosini, M. C. Negri, M. Gonzalez-Leiza, and F. Baquero. 1995. Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases. Antimicrob. Agents Chemother. 39:145-149.
8. Blot, M., B. Hauer, and G. Monnet. 1994. The Tn5 bleomycin resistance gene confers improved survival and growth advantage on Escherichia coli. Mol. Gen. Genet. 242:595-601.
9. Bonny, C., P. E. Montandon, S. M. Martin, and E. Stutz. 1991. Analysis of streptomycin-resistance of Escherichia coli mutants. Biochim. Biophys. Acta 1089:213-219.
10. Bottger, E. C., B. Springer, M. Pletschette, and P. Sander. 1998. Fitness of antibiotic-resistant microorganisms and compensatory mutations. Nat. Med. 4:1343-1344.
11. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
12. Bzymek, M., C. J. Saveson, V. V. Feschenko, and S. T. Lovett. 1999. Slipped misalignment mechanisms of deletion formation: in vivo susceptibility to nucleases. J. Bacteriol. 181:477-482.
13. Charles, I. G., S. Harford, J. F. Brookfield, and W. V. Shaw. 1985. Resistance to chloramphenicol in Proteus mirabilis by expression of a chromosomal gene for chloramphenicol acetyltransferase. J. Bacteriol. 164:114-122.
14. Cohen, S. P., L. M. McMurry, D. C. Hooper, J. S. Wolfson, and S. B. Levy. 1989. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob. Agents Chemother. 33:1318-1325.
15. Davies, J. E. 1997. Origins, acquisition and dissemination of antibiotic resistance determinants. Ciba Found. Symp. 207:15-27.
16. Deplano, A., A. Zekhnini, N. Allali, M. Couturier, and M. J. Struelens. 1997 Association of mutations in grlA and gyrA topoisomerase genes with resistance to ciprofloxacin in epidemic and sporadic isolates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 41:2023-2025.
17. Drake, J. W. 1991. A constant rate of spontaneous mutation in DNA-based microbes. Proc. Natl. Acad. Sci. USA 88:7160-7164.
18. Elena, S. F., and R. E. Lenski. 1997. Test of synergistic interactions among deleterious mutations in bacteria. Nature 390:395-398.
19. Figueiredo, A. M., E. Ha, B. N. Kreiswirth, H. de Lencastre, G. J. Noel, L. Senterfit, and A. Tomasz. 1991. In vivo stability of heterogeneous expression classes in clinical isolates of methicillin-resistant staphylococci. J. Infect. Dis. 164:883-887.
20. Foley, I., P. Marsh, E. M. H. Wellington, A. W. Smith, and M. R. W. Brown. 1999. General stress response master regulator rpoS is expressed in human infection: a possible role in chronicity. J. Antimicrob. Chemother. 43:164-165.
21. Foster, P. L. 1993. Adaptive mutation: the uses of adversity. Annu. Rev. Microbiol. 47:467-504.
22. Foster, P. L, and J. M. Trimarchi. 1994. Adaptive reversion of a frameshift mutation in Escherichia coli by simple base deletions in homopolymeric runs. Science 265:407-409.
23. Giraud, E., A. Brisabois, J. L. Martel, and E. Chaslus-Dancla. 1999. Comparative studies of mutations in animal isolates and experimental in vitro-and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob. Agents Chemother. 43:2131-2137.
24. Hakenbeck, R. 1999. Beta-lactam-resistant Streptococcus pneumoniae: epidemiology and evolutionary mechanism. Chemotherapy (Basel) 45:83-94.
25. Hakenbeck, R., K. Kaminski, M. van der Linden, J. Paik, F. Reichmann, and D. Zähner. 1999. Penicillin-binding proteins in β-lactam-resistant Streptococcus pneumoniae. Microb. Drug Resist. 5:91-99.
26. Hooper, D. C. 1999. Mechanisms of fluoroquinolone resistance. Drug Resist. Updates 2:38-55.
27. Hughes, D., and D. I. Andersson. 1997. Carbon starvation of Salmonella typhimurium does not cause a general increase of mutation rates. J. Bacteriol. 179:6688-6691.
28. Kedderis, G. L., L. S. Argenbright, and G. T. Miwa. 1988. Mechanism of reductive activation of a 5-nitroimidazole by flavoproteins: model studies with dithionite. Arch. Biochem. Biophys. 262:40-48.
29. Kidwell, M. G., and D. R. Lisch. 2000. Transposahle elements and host genome evolution. Trends Ecol. Evol. 15:95-99.
30. Kohler, T., M. Michea-Hamzehpour, P. Plesiat, A. L. Kahr, and J. C. Pechere. 1997. Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41:2540-2543.
31. Korona, R., C. H. Nakatsu, L. J. Forney, and R. E. Lenski. 1994. Evidence for multiple adaptive peaks from populations of bacteria evolving in a structured habitat. Proc. Natl. Acad. Sci. USA 91:9037-9041.
32. LeClerc, J. E., B. Li, W. L. Payne, and T. A. Cebula. 1996. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274: 1208-1211.
33. Lederberg, J., and E. M. Lederberg. 1952. Replica plating and indirect selection of bacterial mutants. J. Bacteriol. 63:399-406.
34. Lenski, R. E. 1997. The cost of antibiotic resistance from the perspective of a bacterium. Ciba Found. Symp. 207:131-140.
35. Luria, S. E., and M. Delbrück. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491-511.
36. Maenhaut Michel, G., and J. A. Shapiro. 1994. The roles of starvation and selective substrates in the emergence of araB-lacZ fusion clones. EMBO J. 13:5229-5239.
37. Mamber, S. W., B. Kolek, K. W. Brookshire, D. P. Bonner, and J. Fung-Tomc. 1993. Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays. Antimicrob. Agents Chemother. 37:213-217.
38. Markham, P. N. 1999. Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine. Antimicrob. Agents Chemother. 43:988-989.
39. Markham, P. N., and A. A. Neyfakh. 1996. Inhibition of the multidrug transporter NorA prevents emergence of norfloxacin resistance in Staphyhcoccus aureus. Antimicrob. Agents Chemother. 40:2673-2674.
40. Martinez, J. L., A. Alonso, J. M. Gomez-Gomez, and F. Baquero. 1998. Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg? J. Antimicrob. Chemother. 42:683-688.
41. Martinez, J. L., E. Cercenado, M. Rodriguez-Creixems, M. F. Vicente-Perez, A. Delgado-Iribarren, and F. Baquero. 1987. Resistance to beta-lactam/clavulanate. Lancet ii:1473.
42. Martinez, J. L., J. Martinez-Suarez, E. Culebras, J. C. Perez-Diaz, and F. Baquero. 1989. Antibiotic inactivating enzymes from a clinical isolate of Agrobacterium radiobacter. J. Antimicrob. Chemother. 23:283-284.
43. Martinez, J. L., and F. Baquero. 1990. Epidemiology of antibiotic-inactivating enzymes and DNA probes: the problem of quantity. J. Antimicrob. Chemother. 26:301-303.
44. Mass, W. K. 1986. Mutations to antibiotic resistance, p. 669-682. In V. Lorian (ed.), Antibiotics in laboratory and medicine, 2nd ed. The Williams & Wilkins Co., Baltimore, Md.
45. Masuda, N., N. Gotoh, C. Ishii, E. Sakagawa, S. Ohya, and T. Nishino. 1999. Interplay between chromosomal β-laccamase and the MexAB-OprM efflux system in intrinsic resistance to β-lactams in Pseudomomas aeruginosa. Antimicrob. Agents Chemother. 43:400-402.
46. Matic, I., M. Radman, F. Taddei, B. Picard, C. Doit, E. Bingen, E. Denamur, and J. Elion. 1997. Highly variable mutation rates in commensal and pathogenic Escherichia coli. Science 277:1833-1834.
47. Mereghetti, L., N. Marquet-van der Mee, J. Loulergue, J. C. Rolland, and A. Audurier. 1998. Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility. Pathol. Biol. 46:319-324.
48. Miller, J. H. 1996. Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair. Annu. Rev. Microbiol. 50:625-643.
49. Miltenhuber, G. 1999. Ocurrence of MazEF-like antitoxin/toxin systems in bacteria. J. Mol. Biotechnol. 1:295-302.
50. Mittler, J. E., and R. E. Lenski. 1990. New data on excisions of Mu from E. coli MCS2 cast doubt on directed mutation hypothesis. Nature 344:173-175.
51. Morosini, M. I., M. C. Negri, B. Shoichet, M. R. Baquero, F. Baquero, and J. Blazquez. 1998. An extended-spectrum AmpC-type beta-lactamase obtained by in vitro antibiotic selection. FEMS Microbiol. Lett. 165:85-90.
52. Moxon, E. R., P. B. Rainey, M. A. Nowak, and R. E. Lenski. 1994. Adaptive evolution of highly mutable loci in pathogenic bacteria. Curr. Biol. 4:2-4-33.
53. Munoz Bellido, J. L., M. A. Alonso Manzanares, G. Yague Guirao, M. N. Gutierrez Zutiaurre, M. C. Toldos, M. Segovia Hernandez, and J. A. Garcia Rodriguez. 1999. In vitro activities of 13 fluoroquinokmes against Staphylo-coccus aureits isolates with characterized mutations in gyrA, grlB, grlA, and norA and against wild-type isolates. Antimicrob. Agents Chemother. 43:966-968.
54. Nakamura, S., M. Nakamura, T. Kojima, and H. Yoshida. 1989. gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob. Agents Chemother. 33:254-255.
55. Nash, K. A., and C. B. Inderlied. 1995. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob. Agents Chemother. 39:2625-2630.
56. Nikaido, H. 1998. Multiple antibiotic resistance and efflux. Curr. Opin. Microbiol. 1:516-523.
57. Phillips, I., E. Culebras, F. Moreno, and F. Baquero. 1987. Induction of the SOS response by new 4-quinolones. J. Antimicrob. Chemother. 20:631-638.
58. Radman, M. 1999. Enzymes of evolutionary change. Nature 401:866-887.
59. Rainey, P. B., and M. Travisano. 1998. Adaptive radiation in a heterogeneous environment. Nature 394:69-72.
60. Reguera, J. A., F. Baquero, J. C. Perez-Diaz, and J. L. Martinez. 1988. Synergistic effect of dosage and bacterial inoculum in TEM-1 mediated antibiotic resistance. Eur. J. Clin. Microbiol, Infect. Dis. 7:778-779.
61. Ren, L., M. S. Rahman, and M. Z. Humayun. 1999. Escherichia coli cells exposed to streptomycin display a mutator phenotype. J. Bacteriol. 181: 1043-1044.
62. Riesenfeld, C., M. Everett, L. J. Piddock, and B. G. Hall. 1997. Adaptive mutations produce resistance to ciprofloxacin. Antimicrob. Agents Che-mother. 41:2059-2061).
63. Rosenberg, S. M., R. S. Harris, and J. Torkelson. 1995. Molecular handles on adaptive mutation. Mol. Microbiol. 18:185-189,
64. Rosenberg, S. M., R. S. Harris, S. Longerich, and A. M. Galloway. 1996. Recombination-dependent mutation in non-dividing cells. Mutat. Res. 350: 69-76.
65. Sander, P., T. Prammananan, A. Meier, K. Frischkorn, and E. C. Bottger. 1997. The role of rihosomal RNAs in macrolide resistance. Mol. Microbiol. 26:469-480.
66. Schrag, S. J., V. Perrot, and B. R. Levin. 1997. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc. R. Soc. London Ser. B 264:1287-1291.
67. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicolinamidase, cause resistance to the antitubcrculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667.
68. Seifert, H. S. 1996. Questions about gonococcal pilus phase and antigenic variation. Mol. Microbiol. 21:433-440.
69. Shapiro, J. A. 1984. Observations on the formation of clones containing araB-lacZ cistron fusions. Mol. Gen. Genet. 194:79-90.
70. Shapiro, J. A. 1997. Genome organization, natural genetic engineering and adaptive mutation. Trends Genet. 13:98-104.
71. Sharp, P. M., D. C. Shields, K. H. Wolfe, and W. H. Li. 1989. Chromosomal location and evolutionary rate variation in enterobacterial genes. Science 246:808-810.
72. Taddei. F., M. Radman, J. Maynard-Smith, B. Toupance, P. H. Gcuyon, and B. Godelle. 1997. Role of mutator alleles in adaptive evolution. Nature 387:700-702.
73. Taylor, D. E., Z. Ge, D. Purych, T. Lo, and K. Hiratsuka. 1997. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob. Agents Chemother. 41:2621-2628.
74. Tenaillon, O., B. Toupance, H. Le Nagard, F. Taddei, and B. Godelle. 1999. Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteria. Genetics I52:485-493.
75. Torres, O. R., R. Z. Korman, S. A. Zahler, and G. M. Dunny. 1991. The conjugative transposon Tn925: enhancement of conjugal transfer by tetracydine in Enterucoccus faecalis and mobilization of chromosomal genes in Bacillus subtilis and E. faecalis. Mol. Gen. Genet. 225:395-400.
76. Willems, R., A. Paul, H. G. van der Heide, A. R. ter Avest, and F. R. Mooi. 1990. Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation. EMBO J. 9:2803-2809.
77. Wolter, J. M., G. Kotsiou, and J. G. McCormack. 1995. Mixed morphotype testing of Pseudomonas aruginosa cultures from cystic fibrosis patients. J. Med. Microbiol. 42:220-224.